IAM

Iambic Therapeutics, Inc. Common Stock

Nasdaq · usd

$14.78+0.52 (+3.61%)

As of 2:19:54 PM EDT on Oct 26, 2026 · 15-minute delayed

Iambic Therapeutics, Inc. Common Stock (IAM) trades at $14.78 (+3.61%) as of 2:19:54 PM EDT on Oct 26, 2026. Market cap is $675.94M, with 1.0 days to cover in short interest.

Stock performance

How Iambic Therapeutics, Inc. Common Stock (IAM) stock has performed from one day to one year, with its 52-week range.

+2.96%

+$0.43 over 1D

1D: +3.61%
1W: -9.58%
1M: —
YTD: -21.87%
1Y: -21.87%
52-wk range: $13.02 – $25.00

Key statistics

Today's trading snapshot for IAM: day range, open, previous close, volume and market cap.

Day range: $14.00 – $15.25
Open: $14.40
Prev close: $14.26
Volume: 92.17K
Market cap: $675.94M
Shares out: 47.4M

Insider buying and selling

In the 12 months to Oct 26, 2026, one IAM insider reported open-market purchases of $11.5M across 1 filing; no open-market sales were filed.

Who traded IAM, and when

Purchase

IAM daily closelast $14.78

Evan Lockwood Rachlin · Director

$11.5M bought

One row per insider; marks sit at the SEC filing date, sized by dollar value.

See who traded and when →

8-K filings

Material corporate events Iambic Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

Charter amendmentOct 16, 2026
On October 16, 2026, Iambic Therapeutics, Inc. (the "Company") filed an amended and restated certificate of incorporation (the "Restated Certificate") with the Secretary of State of the State of Delaware in connection with the completion of the Company's initial public offering (the "IPO").

IAM short interest

How heavily IAM is shorted: shares short, days to cover and average daily volume.

Days to cover: 1.0
Short interest: 7.96K
Avg volume: 9.86K

As of Nov 15, 2018 · reported to FINRA twice monthly.

Frequently asked questions

What is the Iambic Therapeutics, Inc. Common Stock (IAM) stock price today?

Iambic Therapeutics, Inc. Common Stock (IAM) is trading at $14.78 (+3.61% on the day) as of 2:19:54 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Iambic Therapeutics, Inc. Common Stock?

Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

What is the short interest in IAM?

As of Nov 15, 2018, IAM has 7.96K shares short and 1.0 days to cover.

What exchange is IAM listed on?

Iambic Therapeutics, Inc. Common Stock (IAM) trades on Nasdaq in USD.

Build with AI

Build an analysis of IAM with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Claude ChatGPT

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a IAM analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.